ERGOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION

Substituted ergolines of the formula and their acid addition salts, wherein the urea side chain in the 8-position can be in the d alpha - or beta -configuration, C2 C3 and C9 C10 are a CC single or C=C double bond, and R is hydrogen or NR'R'' wherein R'R'' is O2, H2, C1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHNEIDER, HERBERT-HANS, KEHR, WOLFGANG, HAFFER, GREGOR, WACHTEL, HELMUT, SAUER, GERHARD
Format: Patent
Sprache:eng ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCHNEIDER, HERBERT-HANS
KEHR, WOLFGANG
HAFFER, GREGOR
WACHTEL, HELMUT
SAUER, GERHARD
description Substituted ergolines of the formula and their acid addition salts, wherein the urea side chain in the 8-position can be in the d alpha - or beta -configuration, C2 C3 and C9 C10 are a CC single or C=C double bond, and R is hydrogen or NR'R'' wherein R'R'' is O2, H2, C1-4-dialkyl, or, together, they form a 3- to 9-membered ring, or R' and R'' individually are hydrogen, C1-4-alkyl, or C1-10--acyl, R1 is hydrogen, C1-4-alkyl, C1-10-acyl, C6-8-aryl, or C1-4-alkylsulfonyl, R2 is hydrogen or halogen if C2 C3 is a C=C double bond, or hydrogen if C2 C3 is a CC single bond, R6 is C1-4-alkyl, show a pronounced effect on the central nervous system and are suitable, for example, as antidepressants, neuroleptics, or antihypertensives.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0118848B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0118848B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0118848B13</originalsourceid><addsrcrecordid>eNrjZIhwDXL39_H0c1VwcQ3yDHMM8QxzDdZRCAjyd3YNDlZw8w9SCPFw9QwCirgGOAYB5f39FBz9XGCiHo5Bvo7OrqEhns6OPgqOAQE-QAZIEQ8Da1piTnEqL5TmZlBwcw1x9tBNLciPTy0uSExOzUstiXcNMDA0tLAwsXAyNCZCCQCv0DEZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ERGOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION</title><source>esp@cenet</source><creator>SCHNEIDER, HERBERT-HANS ; KEHR, WOLFGANG ; HAFFER, GREGOR ; WACHTEL, HELMUT ; SAUER, GERHARD</creator><creatorcontrib>SCHNEIDER, HERBERT-HANS ; KEHR, WOLFGANG ; HAFFER, GREGOR ; WACHTEL, HELMUT ; SAUER, GERHARD</creatorcontrib><description>Substituted ergolines of the formula and their acid addition salts, wherein the urea side chain in the 8-position can be in the d alpha - or beta -configuration, C2 C3 and C9 C10 are a CC single or C=C double bond, and R is hydrogen or NR'R'' wherein R'R'' is O2, H2, C1-4-dialkyl, or, together, they form a 3- to 9-membered ring, or R' and R'' individually are hydrogen, C1-4-alkyl, or C1-10--acyl, R1 is hydrogen, C1-4-alkyl, C1-10-acyl, C6-8-aryl, or C1-4-alkylsulfonyl, R2 is hydrogen or halogen if C2 C3 is a C=C double bond, or hydrogen if C2 C3 is a CC single bond, R6 is C1-4-alkyl, show a pronounced effect on the central nervous system and are suitable, for example, as antidepressants, neuroleptics, or antihypertensives.</description><language>eng ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1992</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19920219&amp;DB=EPODOC&amp;CC=EP&amp;NR=0118848B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19920219&amp;DB=EPODOC&amp;CC=EP&amp;NR=0118848B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHNEIDER, HERBERT-HANS</creatorcontrib><creatorcontrib>KEHR, WOLFGANG</creatorcontrib><creatorcontrib>HAFFER, GREGOR</creatorcontrib><creatorcontrib>WACHTEL, HELMUT</creatorcontrib><creatorcontrib>SAUER, GERHARD</creatorcontrib><title>ERGOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION</title><description>Substituted ergolines of the formula and their acid addition salts, wherein the urea side chain in the 8-position can be in the d alpha - or beta -configuration, C2 C3 and C9 C10 are a CC single or C=C double bond, and R is hydrogen or NR'R'' wherein R'R'' is O2, H2, C1-4-dialkyl, or, together, they form a 3- to 9-membered ring, or R' and R'' individually are hydrogen, C1-4-alkyl, or C1-10--acyl, R1 is hydrogen, C1-4-alkyl, C1-10-acyl, C6-8-aryl, or C1-4-alkylsulfonyl, R2 is hydrogen or halogen if C2 C3 is a C=C double bond, or hydrogen if C2 C3 is a CC single bond, R6 is C1-4-alkyl, show a pronounced effect on the central nervous system and are suitable, for example, as antidepressants, neuroleptics, or antihypertensives.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1992</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIhwDXL39_H0c1VwcQ3yDHMM8QxzDdZRCAjyd3YNDlZw8w9SCPFw9QwCirgGOAYB5f39FBz9XGCiHo5Bvo7OrqEhns6OPgqOAQE-QAZIEQ8Da1piTnEqL5TmZlBwcw1x9tBNLciPTy0uSExOzUstiXcNMDA0tLAwsXAyNCZCCQCv0DEZ</recordid><startdate>19920219</startdate><enddate>19920219</enddate><creator>SCHNEIDER, HERBERT-HANS</creator><creator>KEHR, WOLFGANG</creator><creator>HAFFER, GREGOR</creator><creator>WACHTEL, HELMUT</creator><creator>SAUER, GERHARD</creator><scope>EVB</scope></search><sort><creationdate>19920219</creationdate><title>ERGOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION</title><author>SCHNEIDER, HERBERT-HANS ; KEHR, WOLFGANG ; HAFFER, GREGOR ; WACHTEL, HELMUT ; SAUER, GERHARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0118848B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; ger</language><creationdate>1992</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHNEIDER, HERBERT-HANS</creatorcontrib><creatorcontrib>KEHR, WOLFGANG</creatorcontrib><creatorcontrib>HAFFER, GREGOR</creatorcontrib><creatorcontrib>WACHTEL, HELMUT</creatorcontrib><creatorcontrib>SAUER, GERHARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHNEIDER, HERBERT-HANS</au><au>KEHR, WOLFGANG</au><au>HAFFER, GREGOR</au><au>WACHTEL, HELMUT</au><au>SAUER, GERHARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ERGOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION</title><date>1992-02-19</date><risdate>1992</risdate><abstract>Substituted ergolines of the formula and their acid addition salts, wherein the urea side chain in the 8-position can be in the d alpha - or beta -configuration, C2 C3 and C9 C10 are a CC single or C=C double bond, and R is hydrogen or NR'R'' wherein R'R'' is O2, H2, C1-4-dialkyl, or, together, they form a 3- to 9-membered ring, or R' and R'' individually are hydrogen, C1-4-alkyl, or C1-10--acyl, R1 is hydrogen, C1-4-alkyl, C1-10-acyl, C6-8-aryl, or C1-4-alkylsulfonyl, R2 is hydrogen or halogen if C2 C3 is a C=C double bond, or hydrogen if C2 C3 is a CC single bond, R6 is C1-4-alkyl, show a pronounced effect on the central nervous system and are suitable, for example, as antidepressants, neuroleptics, or antihypertensives.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; ger
recordid cdi_epo_espacenet_EP0118848B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ERGOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T19%3A07%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHNEIDER,%20HERBERT-HANS&rft.date=1992-02-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0118848B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true